AORT: artivion.com Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand artivion.com (AORT)

The undervalued "rockets" filter by PEG, featured on GURU.Markets, demonstrates investor interest, where the 6.32 mark characterizes this parameter. The dynamics are based on moderate raw material outsourcing coupled with strict internal quality control. Growth is supported by joint research with cardiac centers. Artivion, Inc. (AORT) maintains business stability and protection from market volatility through its impeccable authority in cardiac surgery and physician loyalty.

Artivion, Inc. (AORT) - PEG Multiple from 07/04/2022 to 11/16/2026

Artivion (AORT) - metric breakdowns and financial figures

- current price and projected stock value:
Fundamental company analysis:AORT (Artivion Inc)
Manufactured products of artivion.com

The metric is calculated as the ratio of the P/E multiple to the annual earnings growth rate, allowing for a determination of whether the market value is fair relative to the business development dynamics. A value below one signals undervaluation, which, coupled with high capacity utilization at Artivion, Inc. (AORT) cardiovascular product facilities and capacity upgrades, confirms the growth potential reflected in the PEG ratio.

Competing companies

Growth-Adjusted Market Cap to Net Income Boston Scientific|PEG Multiple EW (Edwards)|RMD (ResMed Inc.) - Market Cap to Earnings and Growth Ratio|PODD: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Corp|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Align Technology Inc (ALGN)|GMED (Globus Medical) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (TransMedics Group Inc)|Price/Earnings to Growth Multiple ATEC (Alphatec)|ENOV (Enovis Corp) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Integra LifeSciences Inc. IART|ESTA - Price/Earnings to Growth Multiple|Beta Bionics, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate IRADIMED CORPORATION|EMBC: PEG Multiple|Growth-Adjusted P/E Ratio TNDM|AXGN (Axogen Surgical) - PEG Multiple|SI-BONE Corp (SIBN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple OFIX|PEG Multiple bioventus.com (BVS)|PEG Multiple KIDS (OrthoPediatrics Corp)|PEG Multiple Treace Medical Concepts Inc TMCI|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight, Inc.) - Price/Earnings to Growth Multiple|ClearPoint Neuro Inc. - Growth-Adjusted Payback Ratio|STXS (Stereotaxis Corporation) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Neuronetics Inc. STIM|Price/Earnings to Growth Ratio Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical VANI|Xtant Medical (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne Medical Technologies Corp.)|Price/Earnings to Growth Ratio modular-medical.com|Price to Earnings Adjusted for Growth Rate myomo.com MYO|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|rewalk.com - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|Growth-Adjusted P/E Ratio IVF|Price/Earnings to Growth Ratio bonebiologics.com|Growth-Adjusted P/E Ratio AXNX (Axonics, Inc)|Price/Earnings to Growth Ratio BIOLASE Inc. (BIOL)|Dynatronics - Growth-Adjusted P/E Ratio|PEG Multiple FNA (Paragon 28 Corp)|invobioscience.com (INVO) - Price to Earnings Adjusted for Growth Rate